Effect of Doxorubicin Plus Olaratumab vs Doxorubicin Plus Placebo on Survival in Patients With Advanced Soft Tissue Sarcomas: The ANNOUNCE Randomized Clinical Trial
Eli Lilly and Company
William D Tap; Andrew J Wagner; Patrick Schöffski; Javier Martin-Broto; Anders Krarup-Hansen; Kristen N Ganjoo; Chueh-Chuan Yen; Albiruni R Abdul Razak; Alexander Spira; Akira Kawai; Axel Le Cesne; Brian A Van Tine; Yoichi Naito; Se Hoon Park; Alexander Fedenko; Zsuzsanna Pápai; Victoria Soldatenkova; Ashwin Shahir; Gary Mo; Jennifer Wright; Robin L Jones; ANNOUNCE Investigators